Breakthru Medicine is advancing a portfolio of innovative cancer therapeutics designed to address critical unmet clinical needs. Founded by industry veterans with decades of experience in successful oncology drug approvals, we combine cutting-edge science with capital-efficient development strategies. Our integrated approach, spanning multiple independent programs and platform technologies, positions us to deliver transformative therapies while creating significant value for stakeholders.